Chongqing Lummy Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 611.968 million compared to CNY 598.615 million a year ago. Operating income was CNY 39.237 million compared to CNY 3.876 million a year ago. Net income was CNY 32.392 million compared to net loss of CNY 8.103 million a year ago. Basic earnings per share from continuing operations was CNY 0.0347 compared to basic loss per share from continuing operations of CNY 0.01 a year ago.